5.50
5.50 (0%)
As of Apr 17, 2025
Recursion Pharmaceuticals, Inc. [RXRX]
Source:
Company Overview
Recursion is a leading clinical stage TechBio company with a mission to decode biology to radically improve lives. We aim to achieve our mission by industrializing drug discovery using the Recursion Operating System (OS), a vertical platform of diverse technologies that enables us to map and navigate trillions of biological, chemical, and patient-centric relationships utilizing approximately 65 petabytes of proprietary data.
| Country | United States |
| Headquarters | salt lake city, utah |
| Phone Number | (385) 269 - 0203 |
| Industry | manufacturing |
| CEO | Christopher Gibson |
| Website | www.recursion.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $58.8 |
| Operating Profit | $-479 |
| Net Income | $-463.7 |
| Net Cash | $201.6 |
Profit Ratios
| Gross Margin | $13.6 |
| Operating Margin | -814.1 |
| Profit as % of Revenues | -2.9% |
| Profit as % of Assets | -44.1% |
| Profit as % of Stockholder Equity | -44.8% |
Management Effectiveness
| Return on Equity | -44.8% |
| Return on Assets | -32% |
| Turnover Ratio | 5.6% |
| EBITA | $-479 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,448.6 |
| Total Liabilities | $413.8 |
| Operating Cash Flow | $-359.2 |
| Investing Cash Flow | $260.1 |
| Financing Cash Flow | $304.1 |
